Drug Approval | January 12, 2022
Marksons Pharma receive final US. FDA approval for Cetirizine Hydrochloride tablets
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
Marksans Pharma has reported consolidated financial results for the period ended September 30, 2021
The company has tied up with OrbiMed as a financial partner for global reach
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)